Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.275
Bid: 1.25
Ask: 1.30
Change: -0.05 (-3.77%)
Spread: 0.05 (4.00%)
Open: 1.325
High: 1.325
Low: 1.275
Prev. Close: 1.325
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 hits record high on BoE vote, UK GDP

Fri, 10th May 2024 12:00

(Alliance News) - Stock prices in London were up at midday on Friday, hitting a record high once again as investors reacted positively to a dovish Bank of England interest rates hold.

Meanwhile, UK gross domestic product data came out before the opening, showing growth above expectations in March and across the first quarter, with the UK officially coming out of a technical recession.

The FTSE 100 index was up 66.70 points, 0.8%, at 8,448.05, after hitting a record high 8,455.77 earlier. The FTSE 250 was up 163.86 points, 0.8%, at 20,695.16, and the AIM All-Share was up 5.05 points, 0.6%, at 788.75.

The Cboe UK 100 was up 0.9% at 844.75, the Cboe UK 250 was up 0.9% at 17,973.70, and the Cboe Small Companies was up 0.3% at 16,089.25.

In European equities on Friday, the CAC 40 in Paris was up 0.9%, while the DAX 40 in Frankfurt was 0.7%.

"The FTSE 100 is again in the ascendancy as the market hit new all-time highs on Friday. Given its international horizons, this has little to do with the UK's better-than-expected GDP growth and is largely being driven by strength in the resources space where higher metals prices and the promise of M&A are helping to stoke share prices," said AJ Bell analyst Russ Mould.

"The next key test of the index's new-found vim and vigour will likely come next week in the form of US inflation figures. Investors have broadly accepted rate cuts won't be as deep or come as soon as would have been anticipated at the start of the year. However, any signs inflation is proving much more stubborn than predicted would still represent a shock to the system for financial markets."

US producer price inflation figures come out on Tuesday next week at 1330 BST, followed by consumer price inflation data at the same time on Wednesday next week.

Stocks in New York were called higher. The Dow Jones Industrial Average was called up 0.3%, the S&P 500 index up 0.3%, and the Nasdaq Composite up 0.4%.

At its May meeting, the Bank of England's Monetary Policy Committee voted by a majority of 7 to 2 to maintain bank rate at 5.25%. Two members preferred to reduce the bank rate by 0.25 percentage points, to 5.00%.

Seven members, Bank of England Governor Andrew Bailey, Sarah Breeden, Ben Broadbent, Megan Greene, Jonathan Haskel, Catherine Mann and Huw Pill, voted in favour of the status quo.

Swati Dhingra and BoE Deputy Governor Dave Ramsden voted for a cut.

The UK economy grew ahead of expectations in March and in the first quarter of 2024, according to numbers on Friday.

According to the Office for National Statistics, UK gross domestic product rose by 0.4% in March from February, ahead of FXStreet cited consensus of 0.1% growth. UK GDP had expanded 0.2% on-month in February, according to revised data.

In the first quarter of 2024, GDP is estimated to have risen 0.6%, beating expectations of a 0.4% rise and following a 0.3% decline in the fourth quarter of 2023 and a 0.1% decline in the third quarter. Compared with the same quarter a year ago, GDP rose 0.2%.

"The UK has charged out of what will go down in the history books as the shortest, shallowest recession on record. After months of floundering around a flatline, growth of 0.6% will give the UK economy a real confidence boost. Services and manufacturing have helped offset ongoing challenges being faced by the construction sector," said AJ Bell analyst Danni Hewson.

"Falling inflation and rising wages have given households a bit more in the tank and they've upped their spend, something that will need to continue if the trajectory is to be maintained. Andrew Bailey painted a bucolic picture of a recovering economy which will be further boosted by any rate cut tailwinds. But the resilience being demonstrated by most sectors could be seen as a reason for MPC members to keep their finger on the pause button for a little while longer."

Sterling was quoted at USD1.2532 at midday on Friday, higher than USD1.2511 at the London equities close on Thursday.

The euro traded at USD1.0780 at midday on Friday, up from USD1.0775 late Thursday. Against the yen, the dollar was quoted at JPY155.74 versus JPY155.61.

In the FTSE 100, miners were among the best performing stocks, with Glencore up 3.3%, Anglo American up 2.0% and Antofagasta up 1.9%.

Gold was quoted at USD2,376.77 an ounce at midday on Friday, higher than USD2,332.88 on Thursday.

British Airways owner IAG rose 0.6%, after it said revenue in the first quarter of 2024 rose to EUR6.43 billion from EUR5.89 billion a year earlier.

Operating profit multiplied to EUR68 million from EUR9 million, while pretax loss narrowed to EUR87 million from EUR121 million.

"Our group benefits from the strength of our core markets - North Atlantic, South Atlantic and intra-Europe - and the performance of our brands. Investment across the group in transformation is delivering encouraging improvements in punctuality and customer experience at our airlines," said Chief Executive Officer Luis Gallego.

"We are well-positioned for the summer. The high demand for travel is a continuing trend. IAG expects non-fuel costs to increase slightly in 2024, reflecting investment. Net debt on March 31 stood at EUR7.44 billion, down from EUR9.25 billion a year earlier."

In the FTSE 250, TBC Bank rose 4.2%.

The Tbilisi, Georgia-based lender announced a share buyback programme of up to GEL75 million or GBP22.4 million, after it reported pretax profit in the first quarter of 2024 rose to GEL343.2 million, or GBP102.3 million, from GEL296.3 million a year earlier.

Total operating income rose to GEL618.0 million from GEL532.2 million, with net interest income up to GEL442.8 million from GEL366.8 million, net fee and commission income up to GEL104.3 million from GEL92.4 million, while other non-interest income ticked down to GEL70.8 million from GEL73.0 million.

TBC Bank's total customer base at March 31 rose to 17.9 million from 13.3 million a year earlier.

Looking ahead, Chief Executive Officer Vakhtang Butskhrikidze commented: "I believe that the group is well positioned to build further on this strong start to the year and deliver excellent results for our shareholders in 2024, as well as ensuring we are on track to meet our strategic targets for next year.

Among London's small-caps, TT Electronics lost 7.7%. In the four months ended April 30, the electronic component manufacturer said revenue falls 2% on an organic basis from a year earlier, but up 1% excluding the impact of pass-through revenues, which it said continue to reduce.

Looking ahead, Chief Executive Officer Peter France commented: "Whilst there is continuing global macro-economic uncertainty, the outlook for our markets remains good. The significant orderbook coverage and our prompt actions across the business underpin the board's confidence in an unchanged outlook for the year and the delivery of the 10% operating margin target."

On AIM in London, Polarean Imaging gained 36%. The medical imaging technology developer said it received its second de novo order for a new Xenon MRI system from the University of Alabama at Birmingham Hospital.

It expects to install the new system later this year and will collaborate "closely" with the hospital team, as it does with its existing clinical sites, to develop a "strong" Xenon MRI programme.

Polarean Imaging said this programme will support clinical imaging, NIH-funded research, and pharmaceutical-sponsored trials, aligning with Polarean's commitment to advancing medical research and patient care.

Brent oil was trading at USD84.42 a barrel at midday on Friday, higher than USD83.62 late Thursday.

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
21 May 2019 12:23

Polarean Imaging Confirms USD1 Million Cystic Fibrosis Trial Grant

LONDON (Alliance News) - Polarean Imaging PLC said Tuesday it had its third USD1 million tranche of a study grant confirmed for its late stage trial of xenon medical imaging for children being for

Read more
13 May 2019 10:44

Polarean Imaging Progresses On Clinical Trials, To Add New Trial Site

LONDON (Alliance News) - Polarean Imaging PLC on Monday said that it is progressing on its phase III clinical trials and plans to add an extra site in its lung resection pathway trial to improve a

Read more
29 Apr 2019 11:44

Polarean Imaging Hires Charles Osborne As Chief Financial Officer

LONDON (Alliance News) - Medical imaging firm Polarean Imaging PLC said Monday it has hired Charles Osborne as its new chief financial officer with immediate effect.Osborne is currently the

Read more
29 Apr 2019 09:24

Polarean names Charles Osborne as new CFO

(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.

Read more
1 Apr 2019 16:48

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

Read more
11 Mar 2019 18:11

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

Read more
15 Feb 2019 13:46

Polarean Imaging Wins Polarizer System Order From Canadian University

LONDON (Alliance News) - Medical imaging products manufacturer Polarean Imaging PLC said Friday that it has secured a order for its latest polarizer system from the University of British Columbia

Read more
15 Feb 2019 10:27

Polarean Imaging enters contract with University of British Columbia

(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.

Read more
3 Jan 2019 11:45

Amati AIM VCT Builds Over 8% Holding In Polarean Imaging (ALLISS)

LONDON (Alliance News) - Polarean Imaging PLC on Thursday said Amati AIM VCT PLC now holds 8.5% stake in the noble gas polarizer devices manufacturing company.Prior to a transaction on AIM

Read more
11 Dec 2018 13:41

Tuesday broker round-up

(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.

Read more
6 Nov 2018 13:55

Polarean Installs Polariser At University Of Missouri, Gets New Order

LONDON (Alliance News) - Polarean Imaging PLC on Tuesday said it installed and commissioned the latest model of its Xenon polariser to the department of Radiology at University of Missouri Health

Read more
3 Oct 2018 10:19

Polarean Imaging Delivers Xenon Polariser To University Of Missouri

LONDON (Alliance News) - Medical technology company Polarean Imaging PLC on Wednesday said the latest model of its Xenon polariser has been delivered to the radiology department at University of

Read more
23 Aug 2018 15:44

UPDATE: Polarean Imaging Enrols First Patient In 129-Xenon MRI Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more
23 Aug 2018 14:53

Polarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon

(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate non-inferiority of its drug-device combination using hyperpolarised 129-Xenon (129Xe) gas MRI, against an approved comparator.

Read more
23 Aug 2018 11:18

Polarean Imaging Enrols First Patient In 129-Xenon MRI Phase III Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.